{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T02:08:31Z","timestamp":1781402911748,"version":"3.54.1"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:p>Clofarabine containing chemotherapeutic regimens have demonstrated efficacy in the treatment of relapsed refractory acute myeloid leukemia. Nonetheless, there are limited data on the use of clofarabine in patients with renal failure. The present report describes the use of clofarabine in a patient with renal failure undergoing intermittent dialysis. We describe our rationale for dosing, clofarabine plasma levels obtained, and discuss our findings in the context of other available literature. Consistent with previous findings, intermittent hemodialysis was not found to be a reliable method of removing clofarabine in patients with renal insufficiency.<\/jats:p>","DOI":"10.1097\/mph.0000000000000845","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T20:51:17Z","timestamp":1495572677000},"page":"481-484","source":"Crossref","is-referenced-by-count":3,"title":["Clofarabine Dosing in a Patient With Acute Myeloid Leukemia on Intermittent Hemodialysis: Case Report and Review of the Literature"],"prefix":"10.1097","volume":"39","author":[{"given":"Lydia L.","family":"Benitez","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University of Michigan Hospitals and Health System"},{"name":"Department of Pharmacy, University of Michigan College of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Gharibian","sequence":"additional","affiliation":[{"name":"Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Frame","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Michigan Hospitals and Health System"},{"name":"Department of Pharmacy, University of Michigan College of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajen","family":"Mody","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Michigan Hospitals and Health System"},{"name":"Department of Pediatrics, Division of Pediatric Hematology\/Oncology, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Mora","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Michigan Hospitals and Health System"},{"name":"Department of Pharmacy, University of Michigan College of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1182\/blood-2003-03-0925","article-title":"Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia","volume":"102","author":"Kantarjian","year":"2003","journal-title":"Blood"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1200\/JCO.2011.37.9743","article-title":"Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the Classic I Trial","volume":"30","author":"Faderl","year":"2012","journal-title":"J Clin Oncol"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1002\/cncr.28674","article-title":"AAML0523: a report from the Children\u2019s Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia","volume":"120","author":"Cooper","year":"2014","journal-title":"Cancer"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/pbc.22458","article-title":"Effect of hemodialysis on the plasma levels of clofarabine","volume":"55","author":"Steinherz","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/ajh.21965","article-title":"Successful management with clofarabine for refractory leukaemia in a young adult with chronic renal failure","volume":"86","author":"Sudour","year":"2011","journal-title":"Am J Hematol"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1177\/0091270004269236","article-title":"Population pharmacokinetics of clofarabine, a second-generation nucleoside analog, in pediatric patients with acute leukemia","volume":"44","author":"Bonate","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1200\/JCO.2008.18.8706","article-title":"Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia","volume":"27","author":"Jeha","year":"2009","journal-title":"J Clin Oncol"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00280-010-1373-2","article-title":"Effective clearance of Ara-U the major metabolite of cytosine arabinoside (Ara-C) by hemodialysis in a patient with lymphoma and end-stage renal failure","volume":"67","author":"Radeski","year":"2011","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201708000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:05:28Z","timestamp":1695009928000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201708000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000845","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}